Clinical Trial Update: Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated quetiapine (Seroquel) for maintenance treatment in early-onset bipolar spectrum disorders; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Mood Disorders Center of Ottawa | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED